Skip to content

8-KAccepted Feb 6, 8:59 AM ET

Revance Therapeutics, Inc. 8-K

Revance Therapeutics, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

8:59 AM

Feb 6, 2025

Filed

Feb 6, 2025

Documents

17

Size

345.7 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.